Cargando…
Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
Tumor initiating stem cells (TISCs) are a subset of tumor cells, which are implicated in cancer relapse and resistance to chemotherapy. The metabolic programs that drive TISC functions are exquisitely unique and finely-tuned by various oncogene-driven transcription factors to facilitate pro-cancerou...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494937/ https://www.ncbi.nlm.nih.gov/pubmed/31106150 http://dx.doi.org/10.3389/fonc.2019.00315 |